Experimental models to study the immunobiology of hepatitis C virus

Journal of General Virology

Volumn 92, Issue 3, 2011, Pages 477-493

  Jo, Juandy ^a,b,d   Lohmann, Volker ^c   Bartenschlager, Ralf ^c   Thimme, Robert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; CHIMPANZEE; DENDRITIC CELL; EXPERIMENTAL MODEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOBIOLOGY; IN VIVO STUDY; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRAL CLEARANCE; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNE EVASION; MODELS, THEORETICAL;

HEPATITIS C VIRUS;

EID: 79951796190     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.027987-0     Document Type: Review

References (171)

1. Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G., Hoofnagle, J. H., Liang, T. J. & other authors (2010). Natural killer cells are polarized towards cytotoxicity in chronic hepatitis C in an interferon-α-dependent manner. Gastroenterology 138, 325-335.
2. Amadei, B., Urbani, S., Cazaly, A., Fisicaro, P., Zerbini, A., Ahmed, P., Missale, G., Ferrari, C. & Khakoo, S. I. (2010). Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138, 1536-1545.
3. Amako, Y., Tsukiyama-Kohara, K., Katsume, A., Hirata, Y., Sekiguchi, S., Tobita, Y., Hayashi, Y., Hishima, T., Funata, N. & other authors (2010). Pathogenesis of hepatitis C virus infection in Tupaia belangeri. J Virol 84, 303-311.
4. Anthony, D. D., Yonkers, N. L., Post, A. B., Asaad, R., Heinzel, F. P., Lederman, M. M., Lehmann, P. V. & Valdez, H. (2004). Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 172, 4907-4916. (Pubitemid 38456415)
5. Arnaud, N., Dabo, S., Maillard, P., Budkowska, A., Kalliampakou, K. I., Mavromara, P., Garcin, D., Hugon, J., Gatignol, A. & other authors (2010). Hepatitis C virus controls interferon production through PKR activation. PLoS ONE 5, e10575.
6. Auffermann-Gretzinger, S., Keeffe, E. B. & Levy, S. (2001). Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97, 3171-3176.
7. Bain, C., Fatmi, A., Zoulim, F., Zarski, J. P., Trepo, C. & Inchauspe, G. (2001). Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120, 512-524. (Pubitemid 32147649)
8. Balachandran, S., Roberts, P. C., Brown, L. E., Truong, H., Pattnaik, A. K., Archer, D. R. & Barber, G. N. (2000). Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13, 129-141.
9. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. & Palucka, K. (2000). Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811. (Pubitemid 30365397)
10. Bartenschlager, R. & Sparacio, S. (2007). Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res 127, 195-207. (Pubitemid 47058197)
11. Barth, H., Robinet, E., Liang, T. J. & Baumert, T. F. (2008). Mouse models for the study of HCV infection and virus-host interactions. J Hepatol 49, 134-142.
12. Bartosch, B., Bukh, J., Meunier, J. C., Granier, C., Engle, R. E., Blackwelder, W. C., Emerson, S. U., Cosset, F. L. & Purcell, R. H. (2003). In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 100, 14199-14204.
13. Bellecave, P., Sarasin-Filipowicz, M., Donze, O., Kennel, A., Gouttenoire, J., Meylan, E., Terracciano, L., Tschopp, J., Sarrazin, C. & other authors (2010). Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. Hepatology 51, 1127-1136.
14. Bigger, C. B., Brasky, K. M. & Lanford, R. E. (2001). DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75, 7059-7066. (Pubitemid 32641593)
15. Bigger, C. B., Guerra, B., Brasky, K. M., Hubbard, G., Beard, M. R., Luxon, B. A., Lemon, S. M. & Lanford, R. E. (2004). Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 78, 13779-13792. (Pubitemid 39612775)
16. Binder, M., Kochs, G., Bartenschlager, R. & Lohmann, V. (2007). Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46, 1365-1374. (Pubitemid 350155518)
17. Bissig, K. D., Wieland, S. F., Tran, P., Isogawa, M., Le, T. T., Chisari, F. V. & Verma, I. M. (2010). Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 120, 924-930.
18. Bitzegeio, J., Bankwitz, D., Hueging, K., Haid, S., Brohm, C., Zeisel, M. B., Herrmann, E., Iken, M., Ott, M. & other authors (2010). Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog 6, e1000978.
19. Blindenbacher, A., Duong, F. H., Hunziker, L., Stutvoet, S. T., Wang, X., Terracciano, L., Moradpour, D., Blum, H. E., Alonzi, T. & other authors (2003). Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 124, 1465-1475. (Pubitemid 36531819)
20. Boisvert, J., He, X. S., Cheung, R., Keeffe, E. B., Wright, T. & Greenberg, H. B. (2001). Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 184, 827-835. (Pubitemid 32881087)
21. Boonstra, A., van der Laan, L. J., Vanwolleghem, T. & Janssen, H. L. (2009). Experimental models for hepatitis C viral infection. Hepatology 50, 1646-1655.
22. Bowen, D. G. & Walker, C. M. (2005). Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946-952. (Pubitemid 41191670)
23. Bukh, J. (2004). A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39, 1469-1475.
24. Bukh, J., Thimme, R., Meunier, J. C., Faulk, K., Spangenberg, H. C., Chang, K. M., Satterfield, W., Chisari, F. V. & Purcell, R. H. (2008). Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain. J Virol 82, 8183-8195.
25. Burlone, M. E. & Budkowska, A. (2009). Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol 90, 1055-1070.
26. Chen, M., Sallberg, M., Sonnerborg, A., Weiland, O., Mattsson, L., Jin, L., Birkett, A., Peterson, D. & Milich, D. R. (1999). Limited humoral immunity in hepatitis C virus infection. Gastroenterology 116, 135-143. (Pubitemid 29013502)
27. Chen, L., Borozan, I., Feld, J., Sun, J., Tannis, L. L., Coltescu, C., Heathcote, J., Edwards, A. M. & McGilvray, I. D. (2005). Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128, 1437-1444. (Pubitemid 40712193)
28. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362. (Pubitemid 19117877)
29. Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P. & Walker, C. M. (1999). Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439-449. (Pubitemid 29205480)
30. Cox, A. L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X. H., Yang, H. C., Sidney, J., Sette, A., Pardoll, D. & other authors (2005). Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201, 1741-1752.
31. Crawford, A. & Wherry, E. J. (2009). The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr Opin Immunol 21, 179-186.
32. + T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J Clin Invest 119, 376-386.
33. Decalf, J., Fernandes, S., Longman, R., Ahloulay, M., Audat, F., Lefrerre, F., Rice, C. M., Pol, S. & Albert, M. L. (2007). Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med 204, 2423-2437.
34. Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Wierenga, E. A., Santantonio, T., Jung, M. C., Eichenlaub, D. & Pape, G. R. (1995). Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006-1007.
35. Dolganiuc, A., Chang, S., Kodys, K., Mandrekar, P., Bakis, G., Cormier, M. & Szabo, G. (2006). Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFNalpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 177, 6758-6768. (Pubitemid 44715040)
36. Dolganiuc, A., Paek, E., Kodys, K., Thomas, J. & Szabo, G. (2008). Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 135, 2119-2127.
37. Dowd, K. A., Netski, D. M., Wang, X. H., Cox, A. L. & Ray, S. C. (2009). Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 136, 2377-2386.
38. Ebihara, T., Shingai, M., Matsumoto, M., Wakita, T. & Seya, T. (2008). Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 48, 48-58. (Pubitemid 351975530)
39. Eksioglu, E. A., Bess, J. R., Zhu, H., Xu, Y., Dong, H. J., Elyar, J., Nelson, D. R. & Liu, C. (2010). Hepatitis C virus modulates human monocyte-derived dendritic cells. J Viral Hepat 17, 757-769.
40. Erickson, A. L., Houghton, M., Choo, Q. L., Weiner, A. J., Ralston, R., Muchmore, E. & Walker, C. M. (1993). Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 151, 4189-4199. (Pubitemid 23298752)
41. Erickson, A. L., Kimura, Y., Igarashi, S., Eichelberger, J., Houghton, M., Sidney, J., McKinney, D., Sette, A., Hughes, A. L. & other authors (2001). The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15, 883-895. (Pubitemid 34075370)
42. Erickson, A. K., Seiwert, S. & Gale, M., Jr (2008). Antiviral potency analysis and functional comparison of consensus interferon, interferon-α2a and pegylated interferon-a2b against hepatitis C virus infection. Antivir Ther 13, 851-862.
43. Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J. & Purcell, R. H. (1996). Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 93, 15394-15399. (Pubitemid 27009611)
44. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J. & other authors (2000). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344. (Pubitemid 30226196)
45. Frese, M., Pietschmann, T., Moradpour, D., Haller, O. & Bartenschlager, R. (2001). Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82, 723-733. (Pubitemid 32280029)
46. Frese, M., Schwärzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O. & Bartenschlager, R. (2002). Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35, 694-703.
47. Fuller, M. J., Shoukry, N. H., Gushima, T., Bowen, D. G., Callendret, B., Campbell, K. J., Hasselschwert, D. L., Hughes, A. L. & Walker, C. M. (2010). Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection. Hepatology 51, 378-387.
48. Gale, M. J., Jr, Korth, M. J., Tang, N. M., Tan, S. L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R. & Katze, M. G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227. (Pubitemid 27211852)
49. Gale, M., Jr, Blakely, C. M., Kwieciszewski, B., Tan, S. L., Dossett, M., Tang, N. M., Korth, M. J., Polyak, S. J., Gretch, D. R. & other authors (1998). Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18, 5208-5218. (Pubitemid 28388104)
50. Garaigorta, U. & Chisari, F. V. (2009). Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 6, 513-522.
51. Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H. & other authors (2009). Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399-401.
52. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M. & Ley, K. (2010). Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661.
53. Gerlach, J. T., Diepolder, H. M., Jung, M. C., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R., Schirren, C. A., Santantonio, T. & other authors (1999). Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 117, 933-941. (Pubitemid 29468237)
54. Golden-Mason, L., Madrigal-Estebas, L., McGrath, E., Conroy, M. J., Ryan, E. J., Hegarty, J. E., O'Farrelly, C. & Doherty, D. G. (2008). Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57, 1121-1128.
55. Goutagny, N., Fatmi, A., De Ledinghen, V., Penin, F., Couzigou, P., Inchauspe, G. & Bain, C. (2003). Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187, 1951-1958. (Pubitemid 36724494)
56. Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J. H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M. & Walker, C. M. (2003). HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659-662. (Pubitemid 37310924)
57. Grebely, J., Conway, B., Raffa, J. D., Lai, C., Krajden, M. & Tyndall, M. W. (2006). Hepatitis C virus reinfection in injection drug users. Hepatology 44, 1139-1145. (Pubitemid 44748365)
58. Haller, O. & Weber, F. (2007). Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol 316, 315-334.
59. Han, J. Q. & Barton, D. J. (2002). Activation and evasion of the antiviral 29-59 oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA 8, 512-525.
60. Helbig, K. J., Lau, D. T., Semendric, L., Harley, H. A. & Beard, M. R. (2005). Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42, 702-710. (Pubitemid 41233665)
61. Hinson, E. R. & Cresswell, P. (2009). The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc Natl Acad Sci U S A 106, 20452-20457.
62. Jo, J., Aichele, U., Kersting, N., Klein, R., Aichele, P., Bisse, E., Sewell, A. K., Blum, H. E., Bartenschlager, R. & other authors (2009). Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 136, 1391-1401.
63. Jones, C. T., Catanese, M. T., Law, L. M., Khetani, S. R., Syder, A. J., Ploss, A., Oh, T. S., Schoggins, J. W., MacDonald, M. R. & other authors (2010). Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol 28, 167-171.
64. Kang, J. I., Kwon, S. N., Park, S. H., Kim, Y. K., Choi, S. Y., Kim, J. P. & Ahn, B. Y. (2009). PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control. Virus Res 142, 51-56.
65. Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A. & Hori, M. (1999). Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162, 5584-5591. (Pubitemid 29307172)
66. Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M. & Wakita, T. (2003). Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808-1817. (Pubitemid 37500445)
67. Kremsdorf, D. & Brezillon, N. (2007). New animal models for hepatitis C viral infection and pathogenesis studies. World J Gastroenterol 13, 2427-2435. (Pubitemid 46929497)
68. Lai, W. K., Curbishley, S. M., Goddard, S., Alabraba, E., Shaw, J., Youster, J., McKeating, J. & Adams, D. H. (2007). Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function. J Hepatol 47, 338-347. (Pubitemid 47176158)
69. Lambotin, M., Baumert, T. F. & Barth, H. (2010). Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells. J Virol 84, 8964-8969.
70. Larkin, J., Boost, A., Glass, J. I. & Tan, S.-L. (2006). Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons. J Interferon Cytokine Res 26, 854-865. (Pubitemid 46025675)
71. Larsson, M., Babcock, E., Grakoui, A., Shoukry, N., Lauer, G., Rice, C., Walker, C. & Bhardwaj, N. (2004). Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J Virol 78, 6151-6161. (Pubitemid 38715913)
72. Lauer, G. M. & Walker, B. D. (2001). Hepatitis C virus infection. N Engl J Med 345, 41-52. (Pubitemid 32634271)
73. Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P. & other authors (2000). Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191, 1499-1512.
74. Lerat, H., Rumin, S., Habersetzer, F., Berby, F., Trabaud, M. A., Trepo, C. & Inchauspe, G. (1998). In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91, 3841-3849.
75. Li, Y., Zhang, T., Ho, C., Orange, J. S., Douglas, S. D. & Ho, W. Z. (2004). Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 76, 1171-1179. (Pubitemid 39602953)
76. Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C., Ikeda, M., Ray, S. C., Gale, M., Jr & Lemon, S. M. (2005). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102, 2992-2997. (Pubitemid 40299904)
77. Liang, H., Russell, R. S., Yonkers, N. L., McDonald, D., Rodriguez, B., Harding, C. V. & Anthony, D. D. (2009). Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol 83, 5693-5707.
78. Lindenbach, B. D., Meuleman, P., Ploss, A., Vanwolleghem, T., Syder, A. J., McKeating, J. A., Lanford, R. E., Feinstone, S. M., Major, M. E. & other authors (2006). Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 103, 3805-3809. (Pubitemid 43376636)
79. Liu, Y. J., Kanzler, H., Soumelis, V. & Gilliet, M. (2001). Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2, 585-589. (Pubitemid 32677624)
80. Liu, C., Zhu, H., Tu, Z., Xu, Y.-L. & Nelson, D. R. (2003). CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology 37, 1335-1342. (Pubitemid 36667313)
81. Liu, L., Fisher, B. E., Dowd, K. A., Astemborski, J., Cox, A. L. & Ray, S. C. (2010). Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection. J Virol 84, 5067-5077.
82. Ljunggren, H. G. & Karre, K. (1985). Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 162, 1745-1759.
83. Logvinoff, C., Major, M. E., Oldach, D., Heyward, S., Talal, A., Balfe, P., Feinstone, S. M., Alter, H., Rice, C. M. & other authors (2004). Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A 101, 10149-10154. (Pubitemid 38891210)
84. Lohmann, V., Körner, F., Koch, J., Herian, U., Theilmann, L. & Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113. (Pubitemid 29307577)
85. Longman, R. S., Talal, A. H., Jacobson, I. M., Albert, M. L. & Rice, C. M. (2004). Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103, 1026-1029.
86. Luquin, E., Larrea, E., Civeira, M. P., Prieto, J. & Aldabe, R. (2007). HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway. Antiviral Res 76, 194-197. (Pubitemid 47410315)
87. Major, M. E., Mihalik, K., Fernandez, J., Seidman, J., Kleiner, D., Kolykhalov, A. A., Rice, C. M. & Feinstone, S. M. (1999). Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol 73, 3317-3325. (Pubitemid 29135725)
88. Major, M. E., Mihalik, K., Puig, M., Rehermann, B., Nascimbeni, M., Rice, C. M. & Feinstone, S. M. (2002). Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 76, 6586-6595. (Pubitemid 34633524)
89. Major, M. E., Dahari, H., Mihalik, K., Puig, M., Rice, C. M., Neumann, A. U. & Feinstone, S. M. (2004). Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 39, 1709-1720. (Pubitemid 38702673)
90. Marcello, T., Grakoui, A., Barba-Spaeth, G., Machlin, E. S., Kotenko, S. V., MacDonald, M. R. & Rice, C. M. (2006). Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131, 1887-1898. (Pubitemid 44958521)
91. Marukian, S., Jones, C. T., Andrus, L., Evans, M. J., Ritola, K. D., Charles, E. D., Rice, C. M. & Dustin, L. B. (2008). Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48, 1843-1850.
92. Matheoud, D., Perie, L., Hoeffel, G., Vimeux, L., Parent, I., Maranon, C., Bourdoncle, P., Renia, L., Prevost-Blondel, A. & other authors (2010). Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo. Blood 115, 4412-4420.
93. Mehta, S. H., Cox, A., Hoover, D. R., Wang, X. H., Mao, Q., Ray, S., Strathdee, S. A., Vlahov, D. & Thomas, D. L. (2002). Protection against persistence of hepatitis C. Lancet 359, 1478-1483. (Pubitemid 34457766)
94. Mengshol, J. A., Golden-Mason, L., Castelblanco, N., Im, K. A., Dillon, S. M., Wilson, C. C. & Rosen, H. R. (2009). Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut 58, 964-973.
95. Mercer, D. F., Schiller, D. E., Elliott, J. F., Douglas, D. N., Hao, C., Rinfret, A., Addison, W. R., Fischer, K. P., Churchill, T. A. & other authors (2001). Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7, 927-933.
96. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R. & Tschopp, J. (2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172. (Pubitemid 41509355)
97. Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M. G., Houghton, M., Fiaccadori, F. & other authors (1996). Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98, 706-714.
98. Mizukoshi, E., Nascimbeni, M., Blaustein, J. B., Mihalik, K., Rice, C. M., Liang, T. J., Feinstone, S. M. & Rehermann, B. (2002). Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies. J Virol 76, 6093-6103. (Pubitemid 34556304)
99. Moradpour, D., Penin, F. & Rice, C. M. (2007). Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463. (Pubitemid 46780082)
100. Muchmore, E., Popper, H., Peterson, D. A., Miller, M. F. & Lieberman, H. M. (1988). Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J Med Primatol 17, 235-246. (Pubitemid 19010406)
101. + T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154. J Hepatol 52, 800-811.
102. Mullins, L. J. & Mullins, J. J. (2004). Insights from the rat genome sequence. Genome Biol 5, 221.
103. Muratori, L., Gibellini, D., Lenzi, M., Cataleta, M., Muratori, P., Morelli, M. C. & Bianchi, F. B. (1996). Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 88, 2768-2774. (Pubitemid 26327532)
104. Nakamoto, N., Kaplan, D. E., Coleclough, J., Li, Y., Kaminski, M., Shaked, A., Olthoff, K., Gostick, E., Price, D. A. & other authors (2008). Functional restoration of HCV-specific CD8 T-cells by PD1 blockade is defined by PD1 expression and compartmentalization. Gastroenterology 134, 1927-1937.
105. Nattermann, J., Zimmermann, H., Iwan, A., von Lilienfeld-Toal, M., Leifeld, L., Nischalke, H. D., Langhans, B., Sauerbruch, T. & Spengler, U. (2006). Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44, 945-954. (Pubitemid 46489559)
106. Neumann-Haefelin, C., Blum, H. E., Chisari, F. V. & Thimme, R. (2005). T cell response in hepatitis C virus infection. J Clin Virol 32, 75-85. (Pubitemid 40093957)
107. + T-cell failure in chronic hepatitis C virus infection. Hepatology 47, 1824-1836.
108. Ohira,M., Ishiyama, K., Tanaka, Y., Doskali,M., Igarashi, Y., Tashiro, H., Hiraga, N., Imamura, M., Sakamoto, N. & other authors (2009). Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. J Clin Invest 119, 3226-3235.
109. Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F., Bruno, S. & Mondelli, M. U. (2009). Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137, 1151-1160.
110. + dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 100, 2858-2866.
111. Pal, S., Sullivan, D. G., Kim, S., Lai, K. K., Kae, J., Cotler, S. J., Carithers, R. L., Jr, Wood, B. L., Perkins, J. D. & other authors (2006). Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 130, 1107-1116.
112. Patzwahl, R., Meier, V., Ramadori, G. & Mihm, S. (2001). Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 75, 1332-1338. (Pubitemid 32097955)
113. Pedersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisari, F. V. & David, M. (2007). Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-922. (Pubitemid 47598616)
114. Pestka, J. M., Zeisel, M. B., Blaser, E., Schurmann, P., Bartosch, B., Cosset, F. L., Patel, A. H., Meisel, H., Baumert, J. & other authors (2007). Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 104, 6025-6030. (Pubitemid 47175652)
115. Pietschmann, T., Zayas, M., Meuleman, P., Long, G., Appel, N., Koutsoudakis, G., Kallis, S., Leroux-Roels, G., Lohmann, V. & other authors (2009). Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog 5, e1000475.
116. Ploss, A. & Rice, C. M. (2009). Towards a small animal model for hepatitis C. EMBO Rep 10, 1220-1227.
117. Ploss, A., Khetani, S. R., Jones, C. T., Syder, A. J., Trehan, K., Gaysinskaya, V. A., Mu, K., Ritola, K., Rice, C. M. & other authors (2010). Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A 107, 3141-3145.
118. Podevin, P., Carpentier, A., Pene, V., Aoudjehane, L., Carriere, M., Zaidi, S., Hernandez, C., Calle, V., Meritet, J. F. & other authors (2010). Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139, 1355-1364.
119. Rauch, A., Kutalik, Z., Descombes, P., Cai, T., Di Iulio, J., Mueller, T., Bochud, M., Battegay, M., Bernasconi, E. & other authors (2010). Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138, 1338-1345.
120. Ray, S. C., Fanning, L., Wang, X. H., Netski, D. M., Kenny-Walsh, E. & Thomas, D. L. (2005). Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 201, 1753-1759. (Pubitemid 41002894)
121. Robert, F., Kapp, L. D., Khan, S. N., Acker, M. G., Kolitz, S., Kazemi, S., Kaufman, R. J., Merrick, W. C., Koromilas, A. E. & other authors (2006). Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2.GTP.Met-tRNA(i)(Met) ternary complex availability. Mol Biol Cell 17, 4632-4644. (Pubitemid 44665734)
122. Rodrigue-Gervais, I. G., Jouan, L., Beaule, G., Sauve, D., Bruneau, J., Willems, B., Sekaly, R. P. & Lamarre, D. (2007). Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol 81, 5537-5546. (Pubitemid 46846994)
123. Rollier, C., Drexhage, J. A., Verstrepen, B. E., Verschoor, E. J., Bontrop, R. E., Koopman, G. & Heeney, J. L. (2003). Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38, 851-858. (Pubitemid 37221668)
124. Saito, K., Ait-Goughoulte, M., Truscott, S. M., Meyer, K., Blazevic, A., Abate, G., Ray, R. B., Hoft, D. F. & Ray, R. (2008a). Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol 82, 3320-3328. (Pubitemid 351429910)
125. Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. & Gale, M., Jr (2008b). Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523-527.
126. Salloum, S., Oniangue-Ndza, C., Neumann-Haefelin, C., Hudson, L., Giugliano, S., aus dem Siepen, M., Nattermann, J., Spengler, U., Lauer, G. M. & other authors (2008). Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs. J Virol 82, 11803-11812.
127. Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H., Christen, V., Terracciano, L., Filipowicz, W. & Heim, M. H. (2008). Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 105, 7034-7039. (Pubitemid 351754525)
128. Sarasin-Filipowicz, M., Krol, J., Markiewicz, I., Heim, M. H. & Filipowicz, W. (2009). Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15, 31-33.
129. + T helper cells in chronic HCV infection. Hepatology 41, 1019-1028.
130. Shepard, C. W., Finelli, L. & Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5, 558-567. (Pubitemid 41196755)
131. Shiina, M. & Rehermann, B. (2008). Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 47, 385-395. (Pubitemid 351280706)
132. Shimoike, T., McKenna, S. A., Lindhout, D. A. & Puglisi, J. D. (2009). Translational insensitivity to potent activation of PKR by HCV IRES RNA. Antiviral Res 83, 228-237.
133. + T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197, 1645-1655.
134. Soderholm, J., Ahlen, G., Kaul, A., Frelin, L., Alheim, M., Barnfield, C., Liljestrom, P., Weiland, O., Milich, D. R. & other authors (2006). Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55, 266-274. (Pubitemid 43117288)
135. + T-cell failure during chronic hepatitis C virus infection. Hepatology 42, 828-837.
136. Stamataki, Z., Grove, J., Balfe, P. & McKeating, J. A. (2008). Hepatitis C virus entry and neutralization. Clin Liver Dis 12, 693-712. (Pubitemid 351952470)
137. Stamataki, Z., Shannon-Lowe, C., Shaw, J., Mutimer, D., Rickinson, A. B., Gordon, J., Adams, D. H., Balfe, P. & McKeating, J. A. (2009). Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells. Blood 113, 585-593.
138. Stegmann, K. A., Bjorkstrom, N. K., Liermann, H., Ciesek, S., Riese, P., Wiegand, J., Hadem, J., Suneetha, P. V., Jaroszewicz, J. & other authors (2010). Interferon alpha induces TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 138, 1885-1897.
139. Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H. & other authors (2002). Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 99, 15669-15674. (Pubitemid 35403989)
140. Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J. & other authors (2009). IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41, 1100-1104.
141. Takahashi, K., Asabe, S., Wieland, S., Garaigorta, U., Gastaminza, P., Isogawa, M. & Chisari, F. V. (2010). Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 107, 7431-7436.
142. Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K. & other authors (2009). Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41, 1105-1109.
143. Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N. & Lai, M. M. (1999). Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285, 107-110. (Pubitemid 29307576)
144. Taylor, D. R., Puig, M., Darnell, M. E., Mihalik, K. & Feinstone, S. M. (2005). New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol 79, 6291-6298. (Pubitemid 40617233)
145. Terenin, I. M., Dmitriev, S. E., Andreev, D. E. & Shatsky, I. N. (2008). Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2. Nat Struct Mol Biol 15, 836-841.
146. Tester, I., Smyk-Pearson, S., Wang, P., Wertheimer, A., Yao, E., Lewinsohn, D. M., Tavis, J. E. & Rosen, H. R. (2005). Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201, 1725-1731.
147. Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C. & Chisari, F. V. (2001). Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194, 1395-1406. (Pubitemid 33081515)
148. Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H. & Chisari, F. V. (2002). Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99, 15661-15668. (Pubitemid 35403988)
149. Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O'Huigin, C., Kidd, J., Kidd, K., Khakoo, S. I. & other authors (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798-801.
150. Timm, J., Lauer, G. M., Kavanagh, D. G., Sheridan, I., Kim, A. Y., Lucas, M., Pillay, T., Ouchi, K., Reyor, L. L. & other authors (2004). CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200, 1593-1604.
151. Timpe, J. M., Stamataki, Z., Jennings, A., Hu, K., Farquhar, M. J., Harris, H. J., Schwarz, A., Desombere, I., Roels, G. L. & other authors (2008). Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47, 17-24. (Pubitemid 351171037)
152. Uebelhoer, L., Han, J. H., Callendret, B., Mateu, G., Shoukry, N. H., Hanson, H. L., Rice, C. M., Walker, C. M. & Grakoui, A. (2008). Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog 4, e1000143.
153. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J. W. & other authors (2007). Dendritic cell subsets in health and disease. Immunol Rev 219, 118-142. (Pubitemid 47393528)
154. Ulsenheimer, A., Gerlach, J. T., Gruener, N. H., Jung, M. C., Schirren, C. A., Schraut, W., Zachoval, R., Pape, G. R. & Diepolder, H. M. (2003). Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37, 1189-1198. (Pubitemid 36538697)
155. Villadangos, J. A. & Young, L. (2008). Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352-361.
156. Virgin, H. W., Wherry, E. J. & Ahmed, R. (2009). Redefining chronic viral infection. Cell 138, 30-50.
157. von Hahn, T., Yoon, J. C., Alter, H., Rice, C. M., Rehermann, B., Balfe, P. & McKeating, J. A. (2007). Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132, 667-678. (Pubitemid 46274668)
158. Wakita, T., Taya, C., Katsume, A., Kato, J., Yonekawa, H., Kanegae, Y., Saito, I., Hayashi, Y., Koike, M. & other authors (1998). Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem 273, 9001-9006.
159. Wakita, T., Katsume, A., Kato, J., Taya, C., Yonekawa, H., Kanegae, Y., Saito, I., Hayashi, Y., Koike, M. & other authors (2000). Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system. J Med Virol 62, 308-317.
160. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G. & other authors (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796. (Pubitemid 41021213)
161. Walters, K. A., Joyce, M. A., Thompson, J. C., Smith, M. W., Yeh, M. M., Proll, S., Zhu, L. F., Gao, T. J., Kneteman, N. M. & other authors (2006). Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response. PLoS Pathog 2, e59.
162. Weiner, A., Erickson, A. L., Kansopon, J., Crawford, K., Muchmore, E., Hughes, A. L., Houghton, M. & Walker, C. M. (1995). Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci U S A 92, 2755-2759.
163. Wertheimer, A. M., Bakke, A. & Rosen, H. R. (2004). Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40, 335-345. (Pubitemid 39062851)
164. Windisch, M. P., Frese, M., Kaul, A., Trippler, M., Lohmann, V. & Bartenschlager, R. (2005). Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol 79, 13778-13793. (Pubitemid 41508189)
165. Witteveldt, J., Evans, M. J., Bitzegeio, J., Koutsoudakis, G., Owsianka, A. M., Angus, A. G., Keck, Z. Y., Foung, S. K., Pietschmann, T. & other authors (2009). CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol 90, 48-58.
166. Xie, Z. C., Riezu-Boj, J. I., Lasarte, J. J., Guillen, J., Su, J. H., Civeira, M. P. & Prieto, J. (1998). Transmission of hepatitis C virus infection to tree shrews. Virology 244, 513-520. (Pubitemid 28384113)
167. Xu, X., Chen, H., Cao, X. & Ben, K. (2007). Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J Gen Virol 88, 2504-2512. (Pubitemid 47323896)
168. Yonkers, N. L., Rodriguez, B., Milkovich, K. A., Asaad, R., Lederman, M. M., Heeger, P. S. & Anthony, D. D. (2007). TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J Immunol 178, 4436-4444. (Pubitemid 46492395)
169. Yoon, J. C., Shiina, M., Ahlenstiel, G. & Rehermann, B. (2009). Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49, 12-21.
170. Zhao, X., Tang, Z. Y., Klumpp, B., Wolff-Vorbeck, G., Barth, H., Levy, S., von Weizsacker, F., Blum, H. E. & Baumert, T. F. (2002). Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J Clin Invest 109, 221-232.
171. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T. & other authors (2005). Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102, 9294-9299. (Pubitemid 40923557)